We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Efficacy and Safety of Masitinib in the Treatment of Progressive Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01433497
Recruitment Status : Completed
First Posted : September 14, 2011
Last Update Posted : April 8, 2020
Information provided by (Responsible Party):
AB Science

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2019
Actual Study Completion Date : February 2020
Certification/Extension First Submitted : March 30, 2020